Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04931888 · ClinicalTrials.gov registry record · NA

Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT04931888 is a NA study that has completed, run by Yale University. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04931888, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

The overall goal of this overall goal is to pilot an adaptation of an established Social-Emotional Learning Program with novel wellness and COVID-19 safety components that are trauma-informed and culturally-specific in a resettled refugee community. In this pilot, "EMPOWER" (Emotions Program Outside the clinic and Wellness Education for Refugees), the study team will assess implementation outcomes (adoption, acceptability, and feasibility) of EMPOWER with refugee children and families during the COVID-19 pandemic through longitudinal evaluations and measurements of feasibility, acceptability, and attrition. The study team will also evaluate the impact of EMPOWER by assessing (a) children's social-emotional learning competence and (b) children's and family's COVID-19 knowledge.

Interventions

  • BEHAVIORAL EMPOWER

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2022-05-20
Est. Completion 2022-08-20
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04931888

The ClinicalTrials.gov registry entry for NCT04931888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EMPOWER is the first listed.

NCT04931888 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04931888 about?

NCT04931888 is a clinical study titled "Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic". The overall goal of this overall goal is to pilot an adaptation of an established Social-Emotional Learning Program with novel wellness and COVID-19 safety components that are trauma-informed and culturally-specific in a resettled refugee community. In this pilot, "EMPOWER" (Emotions Program Outside...

What is the current status of trial NCT04931888?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-05-20. Estimated completion is 2022-08-20.

What interventions are being tested in trial NCT04931888?

The interventions under investigation include: EMPOWER (BEHAVIORAL).

Who is sponsoring clinical trial NCT04931888?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.